Evidence map›Paper›PMID 41136795›Full record

ArticleThe AAPS journal2025

Calibration Transfer Across Instrument Vendors for Bioprocess Raman Monitoring.

Nathaniel M Myers, Beibei Gao, Daniel Amchin, Erin M Masucci, Karin M Balss

Abstract read
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nathaniel M MyersJohnson and Johnson Innovative Medicine, Welsh and McKean Roads Spring House, Spring House, Pennsylvania, 19477, U.S.A.ORCID 0009-0005-3018-6883
Beibei GaoJohnson and Johnson Innovative Medicine, Welsh and McKean Roads Spring House, Spring House, Pennsylvania, 19477, U.S.A.ORCID 0009-0002-5978-6805
Daniel AmchinJohnson and Johnson Innovative Medicine, Welsh and McKean Roads Spring House, Spring House, Pennsylvania, 19477, U.S.A.ORCID 0000-0002-1557-0984
Erin M MasucciJohnson and Johnson Innovative Medicine, Welsh and McKean Roads Spring House, Spring House, Pennsylvania, 19477, U.S.A.ORCID 0000-0002-6863-9041
Karin M BalssJohnson and Johnson Innovative Medicine, Welsh and McKean Roads Spring House, Spring House, Pennsylvania, 19477, U.S.A.. kbalss@its.jnj.com.ORCID 0000-0002-4505-688X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Raman spectroscopy is a proven Process Analytical Technology (PAT) for monitoring mammalian cell culture processes in biopharmaceutical manufacturing. In-line Raman probes provide real-time chemical fingerprints of metabolites and cell culture health analyzed via chemometric modeling. However, Raman hardware (e.g. cables, detectors, optics, probes, and lasers) and software - performing calibration, noise reduction, and cosmic ray removal - impart vendor specific spectral signatures, rendering Raman chemometric models specific to the vendors. This vendor specificity complicates method validation and transfer between manufacturing sites deploying different vendor equipment and impedes upgrades, maintenance, and replacement of obsolete Raman equipment. In this work, we compared two calibration transfer methods to address vendor-to-vendor variation. Piecewise Direct Standardization (PDS) and Spectral Subspace Transformation (SST) methods successfully reduced spectral response variation between previous (Parent) and new (Child) Raman systems. We tested calibration transfer results with offline samples and an established validation approach utilizing paired spectra from Parent and Child Raman systems. Finally, we explored the influence of calibration transfer parameters including training set size, preprocessing position, and window size (number of components) for PDS and SST. Through this investigation we demonstrate the feasibility of this proposed vendor-to-vendor calibration transfer approach as a promising and effective chemometric model transfer between Raman vendors without significant method re-development or re-validation. This approach improves agility within the deployment strategy of chemometric models across supply chain networks and bolsters Raman spectroscopy as a versatile PAT tool for advanced manufacturing within the biopharmaceutical industry.

Indexed as

Spectrum Analysis, RamanCalibrationcalibration transferchemometric modelingpharmaceutical manufacturingProcess Analytical Technology (PAT)raman spectroscopy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.